News
The forgotten feminists: Why older women are still being left behind and what we can do about it

By Ruth Healey, President of Soroptimist International Great Britain and Ireland (SIGBI).
As the world population ages, an uncomfortable truth is emerging: Women over 50 face a double barrier in the workplace.
Older women continue to be trapped at the crossroads of ageism and gender inequality.
Nowhere is this more evident than in leadership roles – both within the workplace, where experienced and capable older women remain underrepresented and overlooked, and beyond it, where older women contribute significantly through paid and unpaid work.
Across all areas of society, the contributions of older women are too often invisible.
A recent report from Age International warns that older women are underrepresented in data and are, therefore, being sidelined. Especially in the decisions that affect them most.
It’s 2025 — supposedly one of the best times to be alive. Yet, even at the heart of the Information Age, crucial data and representation are still missing — and older women continue to pay the price.
From national strategies and workplace policies to social care systems and even annual UK budget statements, older women are being overlooked.
Without urgent action, these gaps will only widen as populations continue to age. But where do we start?
The Problem Expanded
There is a severe lack of representation of older women in the workplace – a gap often overlooked in diversity and inclusion efforts.
While progress has been made on gender and age separately, the unique challenges and contributions of older women remain largely ignored and rarely reflected.
Despite their skills and experience, older women are often overlooked for promotions and leadership roles, held back by biased stereotypes about adaptability and retirement.
The worse part of this? Older women, like me, are used to it. Women face ageism at every age, but the older you get, the worse you feel it.
And, in the workplace, it’s often masked with phrases like “fresh ideas.”
Maybe ageing comes with certain realities. But if that’s true, why are older men seen as wise, while older women are dismissed as outdated or difficult?
Too often, women quietly accept this as the way things are. They carry on, blending into the background.
But we need role models. We need representation. At every age.
Without visible older women in leadership, sexual harassment, hostile work environments and subtle biases will persist.
Access to powerful, capable female leaders must become normal – not the exception. And not a stereotype.
What Happens When Female Leaders Remain Unseen
Research shows that women are the primary victims of age discrimination in hiring which means they are driven out of the workplace earlier than men.
Older women are often pushed into insecure, low-paid, or part-time work, whether by necessity or because full-time, career-advancing roles are increasingly out of reach.
This not only limits their economic independence but also perpetuates the gender pension gap, leaving many financially vulnerable in later life.
Before that, women generally earn less than men at every stage of their careers.
And, by the age of 65, fewer than one in three women remain in employment.
How Can We Change This?
In the workplace small actions can make an immense impact but it’s businesses that must commit to real, measurable change.
Education is key. Companies need to tackle ageism through training, mentorship, and resource groups that support older workers, especially older women.
Despite being widespread, ageism is often easily ignored. Around 92% of companies worldwide don’t include age in their diversity strategies. This must change.
Performance appraisals should focus on skills and achievements, not age. Not gender.
Gradual retirement options would also help by offering older workers greater flexibility. It would help retain valuable experience while ensuring reasonable adjustments are made to support their needs.
Recognising and challenging age bias must become standard practice. Employers also need to address ‘lookism’ – where appearance unfairly affects perceptions of ability.
Work-life balance must be cultivated for employees at every stage of life, not just early career workers.
Above all, workplace focus must shift firmly to skills and experience.
Unconscious bias, or even conscious bias, won’t be unpicked overnight but workplaces must prioritise gender impact assessments across all age groups, with particular focus on older women.
A gender impact assessment is crucial for identifying and addressing how policies, programmes, or decisions affect people differently based on gender.
It can spot hidden inequalities, promote fairness, better decision-making, empower the voices of women, girls and gender-diverse groups, prevent widening gaps, and ultimately drive economic growth and innovation.
Why Supporting Older Women Strengthens The Workplace
Creating truly inclusive, multi-generational workplaces isn’t just fair. It’s vital for business resilience, talent retention, and future success.
Older women can provide younger women in the workplace with mentorship and guidance, offering diverse perspectives and new skills, while fostering stronger teamwork and workplace equality.
Ultimately, workplaces need to be inclusive environments that promote gender and age equality.
They create the conditions to empower younger women to aspire to leadership positions without age-related barriers.
Because when every generation of women is supported to thrive, organisations – and society as a whole – stand to benefit.
Hormonal health
Study links small bowel microbiome differences to women’s health
Menopause
Cancer drug could tackle osteoporosis menopause weight gain

An experimental cancer drug reduced bone loss and body fat in mice modelling post-menopausal changes, early research suggests.
The compound, CADD522, appeared to strengthen bones and help the animals stay leaner after surgery designed to mimic hormonal changes seen after menopause.
The treatment remains at an early experimental stage and has so far only been tested in animals.
The study, led by the University of East Anglia, investigated CADD522, which was originally developed to block a protein involved in the growth and spread of several cancers.
Mice treated with the compound for eight weeks showed significant improvements in bone health. Scans found increased bone volume and better preservation of the honeycomb-like structures inside bones that are crucial for strength and resilience.
Blood tests suggested the treatment stimulated new bone growth without interfering with the body’s normal process of breaking down and rebuilding bone.
Dr Darrell Green, lead researcher from UEA’s Norwich Medical School, said: “Osteoporosis affects around one in three women over the age of 50, leaving sufferers vulnerable to painful fractures that can seriously impact quality of life.
“Current treatments exist, but many are plagued by side effects, safety concerns or inconvenient dosing schedules that make long-term use difficult.”
The researchers also found that mice receiving CADD522 weighed less than untreated mice despite eating the same amount of food.
They had less body fat and fewer fat deposits in their bone marrow, a process commonly seen after menopause and linked to declining bone health.
The team also examined brain tissue and found that the drug appeared to reverse several menopause-related changes in fatty acids.
Levels of omega-3 fats including DHA remained largely intact, while several other lipid abnormalities shifted back towards healthier patterns.
Green said: “We didn’t directly test for memory or thinking ability, but our work raises questions about whether this drug could one day help address wider menopause-related health problems.”
Safety experiments in mice, rats and dogs found that CADD522 could be taken orally and was well tolerated.
The compound also appeared to be metabolised more slowly in human tissue than in rodents, potentially improving its performance in people.
“This is still in the early stages and has so far only been tested in animals but we hope that the benefits will translate to humans to ultimately reduce fracture rates,” added Green.
The research was led by UEA in collaboration with the University of Maryland, the Scintillon Research Institute in San Diego and the University of Stirling.
Safety testing was funded by The Sir William Coxen Trust as part of the development of CADD522 as a childhood cancer treatment.
Fertility
Weight loss surgery improves menstrual health and PMOS symptoms, study finds

Weight loss surgery was linked to more regular periods and fewer polyendocrine metabolic ovarian syndrome (PMOS) symptoms in women aged 18 to 45 living with obesity in a recent study.
The researchers recommend that women undergoing the procedure have access to preconception care and reproductive counselling to support their reproductive health.
Researchers at the University of Surrey analysed data over 24 months from 84 women who underwent bariatric surgery and 18 women living with obesity who did not have surgery.
Of those who underwent surgery, 49 had gastric bypass procedures and 35 had gastric sleeve surgery.
Women who underwent metabolic bariatric surgery lost more than 30kg on average at 12 and 24 months after the procedure.
Among women with polycystic ovaries, the condition persisted in only 10 per cent after 24 months.
Women also reported a resolution of clinical hirsutism, or excess body hair, by 12 months.
Women who had previously experienced irregular periods reported more regular menstrual cycles after surgery.
Professor Martin Whyte, co-author of the study and professor of metabolic medicine at the University of Surrey, said: “A large proportion of those undergoing bariatric surgery are women of reproductive age, who may be planning a pregnancy in the coming years.
“So much remains unknown about the impact of this type of surgery on women who are planning to have children.
“This raises the question of when the ideal time after surgery is to conceive.”
Women have a higher prevalence of obesity than men, with 57 per cent of women in the UK classified as overweight and 27 per cent living with obesity, which can affect fertility and the health of an unborn baby.
The researchers said 17 women had healthy pregnancies following surgery.
Although this was not specifically examined in the study, no difference in birth weight was observed between babies conceived within or after the first year.
Dr Kathryn Hart, co-author of the study and associate professor in nutrition and dietetics at the University of Surrey, said: “What we have found is that bariatric surgery positively affects the reproductive health of women living with obesity and can improve the likelihood of them having a healthy pregnancy after surgery.
“Dysregulated hormone levels, irregular periods and conditions such as polycystic ovaries are affected by obesity.
“By reducing this, what we have seen is that it can lead to improvements without the need for medication.
“We would suggest that clinicians consider medical intervention for obesity to treat irregularities in the menstrual cycle and issues with fertility.”
Hormonal health2 weeks agoMajor UK study could be a ‘game-changer’ for heavy periods and endometriosis
Entrepreneur7 days agoKOVE Medical raises €1.7 million to improve safety of foetal surgery
Fertility2 weeks agoOne week left to apply: W Accelerate with Merck KGaA and M Ventures
Pregnancy1 week agoUK study aims to transform maternity care for high-risk pregnancies
Menopause2 weeks agoQuarter of women miss work due to menstual symptoms, survey finds
Mental health2 weeks agoPMDD after SSRIs or hormones: Why the brain may be the missing treatment target
Diagnosis2 weeks agoArk Surgical secures further institutional backing to accelerate US expansion
Hormonal health5 days agoMenopause hormone treatment may ease brain fog, study suggests













